Clinical Trial Update: Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

View source ↗

Summary

A clinical trial is studying salivary cortisol and hypercortisolism in individuals with type 2 diabetes. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercortisolism
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Hypercortisolism, Type 2 Diabetes (T2DM) | Status: RECRUITING